Olanzapine for people with bipolar disorder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study following people with bipolar disorder who are scheduled to start olanzapine to characterize real-world treatment patterns and outcomes. Participants will provide informed consent, complete surveys, and receive education about olanzapine-associated weight gain while investigators collect clinical and demographic data. The study will compare weight and related outcomes over time between those who receive the educational information and baseline measures. Data will be analyzed to identify factors associated with treatment choices and the effectiveness of the educational approach in preventing weight gain.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who have signed the informed consent after receiving information about the purpose and method of this study.
* Patients diagnosed with bipolar disorder and scheduled to receive olanzapine.
* Patients who understand the contents of the survey and can answer the questions directly.

Exclusion Criteria:

* Female patients who are pregnant, have childbearing potential, or are breastfeeding.
* Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
* Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.

Where it's running

• CHA Bundang Medical Center
  Seongnam, South Korea Recruiting

Study contacts

• Study coordinator: Shinyoung Oh
• Email: syoh@boryung.co.kr
• Phone: +82 2-708-8000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT

  40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.

  Recruiting Medipol University · Istanbul · NCT07534475

• 7T MRI and visual perception markers for severe mood and psychotic disorders

  This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07479758

• Emotional Eating, Sleep Quality, Mental State, and Metabolic Syndrome in Psychiatric Patients

  This study tests how mood, sleep, and emotional eating relate to metabolic syndrome in people with schizophrenia or bipolar disorder.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07411222

• À deux, c'est mieux — group program to improve romantic relationships for young adults with severe mental illness

  This program will try a 12-week, small-group course to help single adults with severe mental illness build skills for dating, communication, and closer social relationships.

  Recruiting at 2 sites Centre hospitalier de Ville-Evrard, France · Épinay-sur-Seine, Île-de-France Region and 1 other locations · NCT07316803

• Brenipatide for adults with bipolar disorder (RENEW-Bipolar-1)

  This trial will test whether adding brenipatide to standard bipolar medications can delay worsening of symptoms in adults with bipolar I or II.

  Recruiting at 84 sites Phase 2 Eli Lilly and Company · Orange, California and 86 other locations · NCT07286175

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.